GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Caplin Point Laboratories Ltd (BOM:524742) » Definitions » Debt-to-Asset

Caplin Point Laboratories (BOM:524742) Debt-to-Asset : 0.00 (As of Jun. 2024)


View and export this data going back to 2001. Start your Free Trial

What is Caplin Point Laboratories Debt-to-Asset?

Caplin Point Laboratories's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2024 was ₹0 Mil. Caplin Point Laboratories's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2024 was ₹0 Mil. Caplin Point Laboratories's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Jun. 2024 was ₹0 Mil.


Caplin Point Laboratories Debt-to-Asset Historical Data

The historical data trend for Caplin Point Laboratories's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Caplin Point Laboratories Debt-to-Asset Chart

Caplin Point Laboratories Annual Data
Trend Jun15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Debt-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.03 0.01 - - -

Caplin Point Laboratories Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Debt-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Caplin Point Laboratories's Debt-to-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, Caplin Point Laboratories's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Caplin Point Laboratories's Debt-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Caplin Point Laboratories's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Caplin Point Laboratories's Debt-to-Asset falls into.



Caplin Point Laboratories Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Caplin Point Laboratories's Debt-to-Asset for the fiscal year that ended in Mar. 2024 is calculated as

Caplin Point Laboratories's Debt-to-Asset for the quarter that ended in Jun. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Caplin Point Laboratories  (BOM:524742) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.


Caplin Point Laboratories Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Caplin Point Laboratories's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Caplin Point Laboratories Business Description

Traded in Other Exchanges
Address
Ashvich Tower, Developed Plots Industrial Estate, No. 3, 3rd Floor, Perungudi, Chennai, TN, IND, 600 096
Caplin Point Laboratories Ltd is the India-based pharmaceutical company. It is engaged in the manufacturing and marketing of pharmaceutical products. The company's key products include tablets, capsules, liquid orals, dry powder, soft gels, penems injections, suppositories. It also provides pharmaceutical formulations in specialized injectable dosage forms and Ophthalmic drops. The business of the company is organized into the following product segments, Antibiotics, Nsaids, Ophthalmics, Pain Management, and Antiulcers. Its products have a presence in the Latin American and African markets.

Caplin Point Laboratories Headlines

No Headlines